Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10080)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 7, 2018 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Boulete IM, Thadi A, Beaufrand C, Patwa V, Joshi A, Foss JA, Eddy EP, Eutamene H, Palejwala VA, Theodorou V, Shailubhai K. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models. World J Gastroenterol 2018; 24(17): 1888-1900 [PMID: 29740204 DOI: 10.3748/wjg.v24.i17.1888] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i17/1888.htm |
| Number | Citing Articles |
| 1 |
Charles F. Barish, Robert A. Crozier, Patrick H. Griffin. Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation. Current Medical Research and Opinion 2019; 35(1): 81 doi: 10.1080/03007995.2018.1527303
|
| 2 |
Dong-ha Kim, Ji-Su Kim, Jae-Hee Kwon, In-Sook Kwun, Moon-Chang Baek, Gi-Seok Kwon, Wiramon Rungratanawanich, Byoung-Joon Song, Do-Kyun Kim, Hyo-Jung Kwon, Young-Eun Cho. Ellagic Acid Prevented Dextran-Sodium-Sulfate-Induced Colitis, Liver, and Brain Injury through Gut Microbiome Changes. Antioxidants 2023; 12(10): 1886 doi: 10.3390/antiox12101886
|
| 3 |
Ariana A. Entezari, Adam E. Snook, Scott A. Waldman. Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential. Expert Opinion on Therapeutic Targets 2021; 25(5): 335 doi: 10.1080/14728222.2021.1937124
|
| 4 |
Martina Rekatsina, Giustino Varrassi. Emerging potential therapies for chronic abdominal visceral pain: an overview. Advancements in Health Research 2024; 1(1) doi: 10.4081/ahr.2024.2
|
| 5 |
Morgan Sendzischew Shane, Johannah Ruddy, Michael Cline, David Rosenbaum, Susan Edelstein, Baharak Moshiree. Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States. Clinical and Experimental Gastroenterology 2024; : 227 doi: 10.2147/CEG.S464375
|
| 6 |
Walter Cabri, Paolo Cantelmi, Dario Corbisiero, Tommaso Fantoni, Lucia Ferrazzano, Giulia Martelli, Alexia Mattellone, Alessandra Tolomelli. Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.697586
|
| 7 |
V. Andresen, G. Becker, T. Frieling, M. Goebel-Stengel, F. Gundling, A. Herold, M. Karaus, J. Keller, M. Kim, P. Klose, H. Krammer, M. E. Kreis, R. Kuhlbusch-Zicklam, J. Langhorst, P. Layer, R. Lenzen-Großimlinghaus, A. Madisch, H. Mönnikes, S. Müller-Lissner, D. Rubin, M. Schemann, J. Schwille-Kiuntke, A. Stengel, M. Storr, I. van der Voort, W. Voderholzer, T. Wedel, S. Wirz, H. Witzigmann, C. Pehl. Aktualisierte S2k-Leitlinie chronische Obstipation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie & Motilität (DGNM) – April 2022 – AWMF-Registriernummer: 021–019. Zeitschrift für Gastroenterologie 2022; 60(10): 1528 doi: 10.1055/a-1880-1928
|
| 8 |
Jeffrey A. Rappaport, Scott A. Waldman. The Guanylate Cyclase C—cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00299
|
| 9 |
David O. Prichard, Adil E. Bharucha. Recent advances in understanding and managing chronic constipation. F1000Research 2018; 7: 1640 doi: 10.12688/f1000research.15900.1
|
| 10 |
Joshua R. Barton, Annie K. Londregan, Tyler D. Alexander, Ariana A. Entezari, Manuel Covarrubias, Scott A. Waldman. Enteroendocrine cell regulation of the gut-brain axis. Frontiers in Neuroscience 2023; 17 doi: 10.3389/fnins.2023.1272955
|
| 11 |
David S. Weinberg, Nathan R. Foster, Gary Della’Zanna, Ryan P. McMurray, Walter K. Kraft, Angela Pallotto, David M. Kastenberg, Leo C. Katz, Christopher H. Henry, Stephanie M. Moleski, Paul J. Limburg, Scott A. Waldman. Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers. Cancer Biology & Therapy 2021; 22(10-12): 544 doi: 10.1080/15384047.2021.1967036
|
| 12 |
Stuart M. Brierley, Luke Grundy, Joel Castro, Andrea M. Harrington, Gerhard Hannig, Michael Camilleri. Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain. Trends in Pharmacological Sciences 2022; 43(2): 110 doi: 10.1016/j.tips.2021.11.002
|
| 13 |
Sarah Adriana Scuderi, Giovanna Casili, Marika Lanza, Alessio Ardizzone, Luca Pantaleo, Michela Campolo, Irene Paterniti, Laura Cucinotta, Salvatore Cuzzocrea, Emanuela Esposito. Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model. International Journal of Molecular Sciences 2022; 23(4): 2269 doi: 10.3390/ijms23042269
|
| 14 |
Liangen Yu, Yihang Li. Involvement of Intestinal Enteroendocrine Cells in Neurological and Psychiatric Disorders. Biomedicines 2022; 10(10): 2577 doi: 10.3390/biomedicines10102577
|
| 15 |
Bowen Tian, Xiaogang Xu, Lin Li, Yan Tian, Yanqing Liu, Yide Mu, Jieting Lu, Kai Song, Junjian lv, Qiuming He, Wei Zhong, Huimin Xia, Chaoting Lan. Epigenetic Insights Into Necrotizing Enterocolitis: Unraveling Methylation-Regulated Biomarkers. Inflammation 2024; doi: 10.1007/s10753-024-02054-x
|
| 16 |
Alison Accarie, Tim Vanuytsel. Animal Models for Functional Gastrointestinal Disorders. Frontiers in Psychiatry 2020; 11 doi: 10.3389/fpsyt.2020.509681
|
| 17 |
Lu-lu Ren, Jia-yi Zhou, Shao-jie Liang, Xiu-qi Wang. Impaired intestinal stem cell activity in ETEC infection: enterotoxins, cyclic nucleotides, and Wnt signaling. Archives of Toxicology 2022; 96(5): 1213 doi: 10.1007/s00204-021-03213-x
|
| 18 |
Chengfeng Xing, Tao Zhang, Xiaolin Liu, Canmei Li, Gang Yang, Hairong Zhang, Rui Wang, Kunhua Wang, Yinglei Miao, Danfeng Lan. Guanylin ligand protects the intestinal immune barrier by activating the guanylate cyclase-C signaling pathway. Acta Histochemica 2022; 124(1): 151811 doi: 10.1016/j.acthis.2021.151811
|
| 19 |
Thomas Kremsmayr, Aws Aljnabi, Juan B. Blanco-Canosa, Hue N. T. Tran, Nayara Braga Emidio, Markus Muttenthaler. On the Utility of Chemical Strategies to Improve Peptide Gut Stability. Journal of Medicinal Chemistry 2022; 65(8): 6191 doi: 10.1021/acs.jmedchem.2c00094
|
| 20 |
Lin Chang, Shahnaz Sultan, Anthony Lembo, G. Nicholas Verne, Walter Smalley, Joel J. Heidelbaugh. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation. Gastroenterology 2022; 163(1): 118 doi: 10.1053/j.gastro.2022.04.016
|
| 21 |
Joshua R. Barton, Annie K. Londregran, Tyler D. Alexander, Ariana A. Entezari, Shely Bar-Ad, Lan Cheng, Angelo C. Lepore, Adam E. Snook, Manuel Covarrubias, Scott A. Waldman. Intestinal neuropod cell GUCY2C regulates visceral pain. Journal of Clinical Investigation 2023; 133(4) doi: 10.1172/JCI165578
|
| 22 |
Laura López-Gómez, Ana Bagüés, José Antonio Uranga, Raquel Abalo. A Comprehensive Overview of Irritable Bowel Syndrome. 2020; : 233 doi: 10.1016/B978-0-12-821324-7.00012-5
|